sciencedaily.com / .sciencedaily-com / Page 3

People who naturally stay up late may be putting their hearts under added strain as they age. A large study tracking more than 300,000 adults found that middle-aged and older night owls had poorer overall heart health and a higher risk of heart ...

Men start developing heart disease earlier than women, with risks rising faster beginning around age 35, according to long-term research. The difference is driven mainly by coronary heart disease, not stroke or heart failure. Traditional risk factors ...

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a dangerous immune reaction that can cause organ ...

On a remote Alaskan island, gray wolves are rewriting the rulebook by hunting sea otters -- a behavior few scientists ever expected to see. Researchers are now uncovering how these coastal wolves adapted to marine hunting, what it means for land-sea ...

Researchers have found a way to make ordinary aluminum tubes float indefinitely, even when submerged for long periods or punched full of holes. By engineering the metal's surface to repel water, the tubes trap air inside and refuse to sink, even in . ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form ...

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old--and how a common drug may slow that process down. Researchers found that SGLT2 inhibitors, widely used to treat diabetes and heart disease, preserved kidney ...

A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels -- a quiet warning sign of future heart disease -- long before ...

Two decades after a breast cancer vaccine trial, every participant is still alive--an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key . ...

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor's own defenses against it. Instead of attacking cancer cells head-on, the experimental immunotherapy targets macrophages--immune cells that tumors ...